rs1568201133
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014649.3(SAFB2):c.2779G>A(p.Val927Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014649.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 248010 AF XY: 0.00000744 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460804Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 726650 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2779G>A (p.V927M) alteration is located in exon 21 (coding exon 21) of the SAFB2 gene. This alteration results from a G to A substitution at nucleotide position 2779, causing the valine (V) at amino acid position 927 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at